Associate Professor of Surgery and Perioperative Care
University of Texas Dell Medical School / Dell Children's Hospital
Carlos Mery, MD, MPH is Associate Chief of Pediatric and Congenital Cardiothoracic Surgery, and the Surgical Director for the Single Ventricle Program, Coronary Anomalies Program, and Heart Failure, VAD, and Transplant Program within the Texas Center for Pediatric and Congenital Heart Disease, a clinical partnership between UT Health Austin and Dell Children’s Medical Center. He specializes in the management of children and adults with congenital heart disease, including simple and complex congenital heart defects. Dr. Mery is Associate Professor of Surgery and Perioperative Care, and Pediatrics, at Dell Medical School at The University of Texas at Austin.
Dr. Mery received his medical degree from Tecnológico De Monterrey, Mexico and his MPH from Harvard School of Public Health. He completed his general surgery residency at Brigham and Women’s Hospital / Harvard Medical School and clinical fellowships in cardiothoracic surgery at the University of Virginia and congenital heart surgery at Texas Children’s Hospital / Baylor College of Medicine. He also completed research fellowships at Brigham and Women’s Hospital and the Instituto Nacional de la Nutrición in Mexico, and a surgical innovation fellowship at Stanford University.
Dr. Mery is an active researcher and educator. His academic interests include clinical outcomes research and the early development of medical technology. As the Director of the Health Transformation and Design Program, Dr. Mery is passionate about improving the lifetime journey of individuals with congenital heart disease and their families. He has forged close relationships with the Value Institute for Health and Care and the Design Institute for Health to advance the holistic care of individuals with congenital heart disease. Dr. Mery has written more than 150 journal articles or book chapters and is the editor of a review book in cardiothoracic surgery and a handbook in congenital heart disease.
Nothing to disclose
Saturday, January 29, 2022
12:30 PM – 1:30 PM ET